439940-89-3

Upstream product

• 17696-11-6 8-bromooctanoic acid 
• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 68641-49-6 bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride 
• 144-55-8 sodium hydrogencarbonate 

Downstream Products

• 439940-91-7 8-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-octanoic acid benzyloxyamide 
• 439940-95-1 8-(6,7-dimethoxy-1-phenyl-3,4-dihydro-1H-isoquinolin-2-yl)-octanoic acid benzyloxyamide 
• 439940-94-0 8-(6,7-diethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-octanoic acid benzyloxyamide 
• 439940-93-9 8-(6,7-dimethoxy-3-methyl-3,4-dihydro-1H-isoquinolin-2-yl)-octanoic acid benzyloxyamide 
• 439940-92-8 8-(1-isopropyl-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-octanoic acid benzyloxyamide 
• 439940-90-6 8-(3,4-dihydro-1H-isoquinolin-2-yl)-octanoic acid benzyloxy-amide 
• 439940-96-2 8-(1,3,4,9-tetrahydro-β-carbolin-2-yl)-octanoic acid benzyloxyamide 

Relevant academic research and scientific papers

Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors

A compound of the formula (I) wherein A, R1, R2 and X have the meanings defined in the specification, process of manufacturing such as compound and a pharmaceutical composition with HDAC inhibitor activity and anti-cell proliferation

Tricyclic alkylhydroxamate derivatives

Compounds of formula I wherein R1, R2, A, X, Y and Z have the meanings provided in the specification, and their enantiomers, diastereoisomers, racemates, pharmaceutically acceptable salts and mixtures thereof. These compounds have HDAC inhibitory activity